Executive Report-5

COVID-19 Resources Get Federal, State, Organization and other information. more info Find Treatment Search our national database of treatment an other related resources. more info NAMA Library Get Federal, State, Organization and other information. more info We offer information about your rights under HIPPA and answers to frequently asked questions about the HIPPA rules. HIPPA…

Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…

 Note On This Page   Admission Requirements  Homes  Take Home Exceptions  (a) The Food and Drug Administration and the Drug Enforcement Administration recognize that the investigational use of methadone requiring the prolonged maintenance of narcotic dependence as part of a total treatment effort has shown promise in the management and rehabilitation of selected narcotic addicts. It…

Basic Information About Buprenorphine Federal Law For the first time in nearly a century physicians may now treat opiate addiction. On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of certain medications to treat opiate addiction. Physicians may now prescribe Schedule III, IV, and V…

Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) Telephone (240) 276-2717 1Choke Cherry Road, Room 2-1065 Facsimile (240) 276-1630 Rockville, Maryland 20857 E-mail: [email protected] Division of Pharmacologic Therapies DPT C. Todd Rosendale, MA Public Health Advisor ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE AInformation Memorandum@   This facsimile is intended only for the addressee…